Sarepta Therapeutics (SRPT) Q4 2020 Earnings

5NovConfirmed
Q1 2020
Q2 2020
Q3 2020
Q4 2020
-3.16
-2.18
-1.21
-0.23

Details

Expected EPS
-1.71
Actual EPS
-1.93
Surprise EPS
-0.22
Surprise Percent
+12.87%

Description

Sarepta Therapeutics (SRPT) has reported earnings of -1.93 per share for Q4 2020.

0 Comments

Share your thoughts